In this issue:
Generalisability of the EAST-AFNET 4 trial
Diabetes and progression of HF
Sedentary time, physical activity, and stroke risk
Thromboembolic risk in patients with pneumonia and new-onset AF
Mortality in patients with early-onset AF and rare variants in cardiomyopathy and arrhythmia genes
Prognostic value of CAC zero in patients presenting with chest pain
Rivaroxaban monotherapy vs dual antiplatelet therapy in patients with AF and CAD
SGLT2 inhibitors and cardiac outcomes among patients treated with anthracyclines
Impact of BP levels in early 40s on left atrial dimensions in mid-60s
Enrolment of female participants in clinical trials
Please login below to download this issue (PDF)